Details of the Drug

General Information of Drug (ID: DM0HYFU)

Drug Name

Epstein-barr virus-specific immunotherapy

Synonyms

Epstein-barr virus-specific immunotherapy (nasopharyngeal carcinoma)

Indication

Disease Entry	ICD 11	Status	REF
Nasopharyngeal carcinoma	2B6B	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00834093) A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma. U.S. National Institutes of Health.